480 related articles for article (PubMed ID: 15019071)
1. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
[TBL] [Abstract][Full Text] [Related]
2. Complex of 9-nitro-camptothecin in hydroxypropyl-beta-cyclodextrin: in vitro and in vivo evaluation.
Jiang Y; Sha X; Zhang W; Fang X
Int J Pharm; 2010 Sep; 397(1-2):116-21. PubMed ID: 20637848
[TBL] [Abstract][Full Text] [Related]
3. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
4. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
Wu WM; Wu J; Bodor N
Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
8. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
9. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
[TBL] [Abstract][Full Text] [Related]
10. A stable water-soluble tetramethylbenzidine-2-hydroxypropyl-beta-cyclodextrin inclusion complex and its applications in enzyme assays.
Cattaneo MV; Luong JH
Anal Biochem; 1994 Dec; 223(2):313-20. PubMed ID: 7887477
[TBL] [Abstract][Full Text] [Related]
11. Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Ventura CA; Giannone I; Musumeci T; Pignatello R; Ragni L; Landolfi C; Milanese C; Paolino D; Puglisi G
Eur J Med Chem; 2006 Feb; 41(2):233-40. PubMed ID: 16387393
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complexation of diazepam with different cyclodextrins in formulations for parenteral use.
Holvoet C; Heyden YV; Plaizier-Vercammen J
Pharmazie; 2005 Aug; 60(8):598-603. PubMed ID: 16124403
[TBL] [Abstract][Full Text] [Related]
13. Sildenafil/cyclodextrin complexation: stability constants, thermodynamics, and guest-host interactions probed by 1H NMR and molecular modeling studies.
Al Omari MM; Zughul MB; Davies JE; Badwan AA
J Pharm Biomed Anal; 2006 Jun; 41(3):857-65. PubMed ID: 16527440
[TBL] [Abstract][Full Text] [Related]
14. Improvement of solubility and oral bioavailability of rutin by complexation with 2-hydroxypropyl-beta-cyclodextrin.
Miyake K; Arima H; Hirayama F; Yamamoto M; Horikawa T; Sumiyoshi H; Noda S; Uekama K
Pharm Dev Technol; 2000; 5(3):399-407. PubMed ID: 10934740
[TBL] [Abstract][Full Text] [Related]
15. Influence of preparation methodology on solid-state properties of an acidic drug-cyclodextrin system.
Govindarajan R; Nagarsenker MS
J Pharm Pharmacol; 2004 Jun; 56(6):725-33. PubMed ID: 15231037
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation and Stabilization of α-Lipoic Acid in Cyclodextrin Inclusion Complex Electrospun Nanofibers: Antioxidant and Fast-Dissolving α-Lipoic Acid/Cyclodextrin Nanofibrous Webs.
Celebioglu A; Uyar T
J Agric Food Chem; 2019 Nov; 67(47):13093-13107. PubMed ID: 31693349
[TBL] [Abstract][Full Text] [Related]
17. Novel inclusion complex of ibuprofen tromethamine with cyclodextrins: physico-chemical characterization.
Al Omari MM; Daraghmeh NH; El-Barghouthi MI; Zughul MB; Chowdhry BZ; Leharne SA; Badwan AA
J Pharm Biomed Anal; 2009 Oct; 50(3):449-58. PubMed ID: 19545961
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclodextrin complexation on aqueous solubility and photostability of phenothiazine.
Lutka A
Pharmazie; 2000 Feb; 55(2):120-3. PubMed ID: 10723770
[TBL] [Abstract][Full Text] [Related]
19. Enhanced oral absorption of saquinavir with Methyl-Beta-Cyclodextrin-Preparation and in vitro and in vivo evaluation.
Pathak SM; Musmade P; Dengle S; Karthik A; Bhat K; Udupa N
Eur J Pharm Sci; 2010 Nov; 41(3-4):440-51. PubMed ID: 20656025
[TBL] [Abstract][Full Text] [Related]
20. Development and pharmacological evaluation of ropivacaine-2-hydroxypropyl-beta-cyclodextrin inclusion complex.
de Araujo DR; Tsuneda SS; Cereda CM; Del G F Carvalho F; Preté PS; Fernandes SA; Yokaichiya F; Franco MK; Mazzaro I; Fraceto LF; de F A Braga A; de Paula E
Eur J Pharm Sci; 2008 Jan; 33(1):60-71. PubMed ID: 18036789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
